|
Code
|
8686C
|
|
MA number
|
16/0033/02-S
|
|
Product Form:
|
sol inj 30x0,8 ml/120 mg (striek.inj.napl.skl.) s bezp.systémom (P)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
Sanofi Winthrop Industrie, France
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B01 |
ANTITHROMBOTIC AGENTS |
| B01A |
ANTITHROMBOTIC AGENTS |
| B01AB |
Heparin group |
| B01AB05 |
Enoxaparin |
|
|
Shelf life:
|
24 |
|
Container:
|
glass pre-filled syringe
|
|
Route of admin.:
|
Subcutaneous use
|
SPC_CLEXANE FORTE_06.2023.pdf
